News Results for Glaxosmithkline (GSK)

Hal Barron, Executive Director, bought 2,269 shares in the company on the 23rd November 2020 at a price of $18.37. The Director now holds 385,147 shares. Story provided by StockMarketWire.com...

Gulf Keystone Petroleum said it had completed its planned workover on the SH-12 well in Iraq and expected output within the top end of its guidance range. The company confirmed that average 2020...

Hal Barron, Executive Director, has re-invested 86 shares in the company on the 12th November 2020 at a price of $18.88. The Director now holds 382,878 shares. Story provided by...

Hal Barron, Executive Director, has re-invested 3,872 shares in the company on the 12th November 2020 at a price of $18.88. The Director now holds 382,792 shares. Story provided by...

Pharmaceutical giant GSK and Canadian biopharmaceutical firm Medicago have announced the start of phase 2 and 3 clinical trials of a Covid-19 vaccine candidate. The trials will seek to evaluate...

Hal Barron, Executive Director, bought 2,223 shares in the company on the 9th November 2020 at a price of $18.75. The Director now holds 378,920 shares. Story provided by StockMarketWire.com...

Emma Walmsley, Director, has transferred in 9 shares in the company on the 10th November 2020 at a price of £0.00. The Director now holds 787,621 shares. Story provided by StockMarketWire.com...

Emma Walmsley, Director, bought 9 shares in the company on the 10th November 2020 at a price of £14.62. The Director now holds 787,612 shares. Story provided by StockMarketWire.com Director deals...

The FTSE 100 exploded into life just before lunch on Monday on news that a vaccine being developed by Pfizer is 90% effective against Covid. The FTSE 100 was up 3.4% to 6,112.64 on hopes that the...

The FTSE 100 rose after markets opened this morning as enthusiasm stayed strong in the aftermath of Joe Biden's US election victory. British house builder Taylor Wimpey has said it expects to end...

Glaxo's specialist HIV company ViiV Healthcare reported that interim analysis from the HPTN 084 study shows long-acting injectable cabotegravir administered every two months is 89% more effective...

Hal Barron, Executive Director, bought 296,993 shares in the company on the 29th October 2020 at a price of $16.98. The Director now holds 376,697 shares. Story provided by StockMarketWire.com...

Hal Barron, Executive Director, bought 6,748 shares in the company on the 29th October 2020 at a price of $16.98. The Director now holds 79,704 shares representing 0.00% of the shares in issue....

Jonathan Symonds, Chairman, bought 15,000 shares in the company on the 29th October 2020 at a price of £13.15. The Director now holds 47,608 shares representing 0.00% of the shares in issue. Story...

Jonathan Symonds, Chairman, sold 8,944 shares in the company on the 29th October 2020 at a price of £13.17. The Director now holds 32,608 shares representing 0.00% of the shares in issue. Story...

Jesse Goodman, Director, bought 752 shares in the company on the 28th October 2020 at a price of $17.65. The Director now holds 9,216 shares representing 0.00% of the shares in issue. Story...

Vivienne Cox, Non Executive Director, bought 625 shares in the company on the 28th October 2020 at a price of £13.50. The Director now holds 7,202 shares representing 0.00% of the shares in issue....

Charles Bancroft, Non Executive Director, bought 1,733 shares in the company on the 28th October 2020 at a price of $17.65. The Director now holds 2,735 shares representing 0.00% of the shares in...

Manvinder Singh Banga, Non Executive Director, bought 671 shares in the company on the 28th October 2020 at a price of £13.50. The Director now holds 63,092 shares representing 0.00% of the shares...

Urs Rohner, Director, bought 625 shares in the company on the 28th October 2020 at a price of £13.50. The Director now holds 12,754 shares representing 0.00% of the shares in issue. Story provided...

Laurie Glimcher, Non Executive Director, bought 2,280 shares in the company on the 28th October 2020 at a price of $17.65. The Director now holds 20,154 shares representing 0.00% of the shares in...

Jonathan Symonds, Chairman, bought 3,241 shares in the company on the 28th October 2020 at a price of £13.50. The Director now holds 41,552 shares representing 0.00% of the shares in issue. Story...

Lynn Elsenhans, Non Executive Director, bought 1,231 shares in the company on the 28th October 2020 at a price of $17.65. The Director now holds 43,117 shares representing 0.00% of the shares in...

Judy Lewent, Non Executive Director, bought 798 shares in the company on the 28th October 2020 at a price of $17.65. The Director now holds 30,249 shares representing 0.00% of the shares in issue....

The market has decided it needs to panic about coronavirus amid the threat of new national lockdowns with the FTSE 100 hitting its lowest level since April as it closed down 2.55% at 5,582.80....

Pharmaceutical company GlaxoSmithKline warned that it expected to post annual earnings at the lower end of its guidance range after its operating profit fell 13% in the third quarter. The company...

FTSE 100 stabilises but still down more than 1.5% amid Covid fears The FTSE 100 was down 1.7% to 5,629.42, off its six-month lows from this morning but still heavily in negative territory as...

UK stocks opened substantially lower on Wednesday amid increasing fears that European countries including Britain, France and Germany would re-introduce national lockdowns amid an alarming surge in...

Drugmakers Sanofi and GlaxoSmithKline said they had signed a statement of intent with Gavi to distribute eventual Covid-19 vaccines. Under the agreement, the companies said they would make...

GlaxoSmithKline's ViiV Healthcare joint venture with Pfizer and Shionogi said it had received a positive opinion recommending marketing authorisation from European regulators for a long-acting HIV...

Emma Walmsley, Director, has re-invested 714 shares in the company on the 12th October 2020 at a price of £14.25. The Director now holds 783,902 shares. Story provided by StockMarketWire.com...

Emma Walmsley, Director, has re-invested 891 shares in the company on the 12th October 2020 at a price of £14.25. The Director now holds 782,301 shares. Story provided by StockMarketWire.com...

Emma Walmsley, Director, has re-invested 887 shares in the company on the 12th October 2020 at a price of £14.25. The Director now holds 783,188 shares. Story provided by StockMarketWire.com...

Iain Mackay, Financial Director, has re-invested 482 shares in the company on the 12th October 2020 at a price of £14.25. The Director now holds 36,655 shares representing 0.00% of the shares in...

Emma Walmsley, Director, has re-invested 3,701 shares in the company on the 12th October 2020 at a price of £14.25. The Director now holds 787,603 shares. Story provided by StockMarketWire.com...

Hal Barron, Executive Director, has re-invested 818 shares in the company on the 12th October 2020 at a price of $18.58. The Director now holds 72,956 shares representing 0.00% of the shares in...

Hal Barron, Executive Director, has re-invested 1,042 shares in the company on the 12th October 2020 at a price of $18.58. The Director now holds 72,138 shares representing 0.00% of the shares in...

Emma Walmsley, Director, has re-invested 26 shares in the company on the 8th October 2020 at a price of £14.26. The Director now holds 779,171 shares. Story provided by StockMarketWire.com...

Emma Walmsley, Director, has transferred in 8 shares in the company on the 9th October 2020 at a price of £0.00. The Director now holds 779,187 shares. Story provided by StockMarketWire.com...

Emma Walmsley, Director, bought 8 shares in the company on the 9th October 2020 at a price of £14.40. The Director now holds 779,179 shares. Story provided by StockMarketWire.com Director deals...

Emma Walmsley, Director, has re-invested 2,223 shares in the company on the 9th October 2020 at a price of £14.40. The Director now holds 781,410 shares. Story provided by StockMarketWire.com...

Emma Walmsley, Director, bought 8 shares in the company on the 10th September 2020 at a price of 15.203500p. The Director now holds 779,137 shares. Story provided by StockMarketWire.com Director...

Emma Walmsley, Director, has transferred in 8 shares in the company on the 10th September 2020 at a price of 0.000000p. The Director now holds 779,145 shares. Story provided by...

UK shares turned-down sharply on Thursday afternoon following US stocks lower on the biggest tech stock weakness seen since March with the Nasdaq 100 falling more than 5%. After strong gains over...

UK markets have been lifted following an appearance by Bank of England governor Andrew Bailey before the Treasury Select Committee yesterday (2 September) in which he said UK interest rates could...

Drugmakers GSK and Sanofi announced they would begin a phase 1/2 clinical trial for their potential COVID-19 vaccine and expected first results from the study in early December 2020. Positive...

Morgan Stanley today reaffirms its underweight investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to 1700p (from 1725p). Story provided by StockMarketWire.com Broker...

Emma Walmsley, Director, has transferred in 8 shares in the company on the 11th August 2020 at a price of 0.000000p. The Director now holds 779,129 shares. Story provided by StockMarketWire.com...

Emma Walmsley, Director, bought 8 shares in the company on the 11th August 2020 at a price of 15.978500p. The Director now holds 779,121 shares. Story provided by StockMarketWire.com Director...

UBS today reaffirms its buy investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to 1800p (from 1920p). Story provided by StockMarketWire.com Broker Forecasts data provided...

Pharmaceutical company GlaxoSmithKline said the US Food and Drug Administration had approved its a drug used to treat blood cancer patients. The drug, BLENREP, was approved as s a monotherapy...

UK stocks reversed opening softness to put in a late morning surge on Monday as investors shrugged-off geopolitical worries and soaring losses posted by HSBC, the UK's largest listed bank. At...

UK stocks opened lower on Monday after HSBC revealed hefty credit losses related to the Covid-19 crisis and aerospace engineering Senior announced another round of job cuts. At 0828, the benchmark...

Sanofi and GlaxoSmithKline said they were in 'advanced discussions' with the European Commission to supply up to 300m doses of a Covid-19 vaccine. The vaccine candidate developed by Sanofi in...

Pharmaceutical company GlaxoSmithKline said it and partner Sanofi had been selected by the US government to participate in the 'operation warp speed' effort to develop a vaccine for Covid-19. The...

DZ Bank today reaffirms its buy investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to 1850p (from 1900p). Story provided by StockMarketWire.com Broker Forecasts data...

Goldman Sachs today reaffirms its buy investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to 2020p (from 2060p). Story provided by StockMarketWire.com Broker Forecasts...

Credit Suisse today reaffirms its neutral investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to 1700p (from 1860p). Story provided by StockMarketWire.com Broker Forecasts...

Jesse Goodman, Director, bought 769 shares in the company on the 29th July 2020 at a price of 20.410000p. The Director now holds 8,464 shares representing 0.00% of the shares in issue. Story...

Urs Rohner, Director, bought 531 shares in the company on the 29th July 2020 at a price of 15.890000p. The Director now holds 12,129 shares representing 0.00% of the shares in issue. Story...

Vivienne Cox, Non Executive Director, bought 688 shares in the company on the 29th July 2020 at a price of 15.890000p. The Director now holds 6,577 shares representing 0.00% of the shares in...

Charles Bancroft, Non Executive Director, bought 1,002 shares in the company on the 29th July 2020 at a price of 20.410000p. The Director now holds 1,002 shares representing 0.00% of the shares in...

Jonathan Symonds, Chairman, bought 2,753 shares in the company on the 29th July 2020 at a price of 15.890000p. The Director now holds 38,311 shares representing 0.00% of the shares in issue. Story...

Manvinder Singh Banga, Non Executive Director, bought 570 shares in the company on the 29th July 2020 at a price of 15.890000p. The Director now holds 62,421 shares representing 0.00% of the shares...

Judy Lewent, Non Executive Director, bought 808 shares in the company on the 29th July 2020 at a price of 20.410000p. The Director now holds 29,451 shares representing 0.00% of the shares in...

Laurie Glimcher, Non Executive Director, bought 2,445 shares in the company on the 29th July 2020 at a price of 20.410000p. The Director now holds 17,874 shares representing 0.00% of the shares in...

Lynn Elsenhans, Non Executive Director, bought 1,301 shares in the company on the 29th July 2020 at a price of 20.410000p. The Director now holds 41,886 shares representing 0.00% of the shares in...

UK stocks ended Wednesday virtually flat ahead of the US Federal Reserve vote on interest rates this evening. Market indecision plagued the FTSE 100, but Wall Street was in positive mood with the...

Pharmaceutical company GlaxoSmithKline said that meeting its annual earnings guidance was contingent on the timing of a recovery in vaccine demand, a slump in which drove a fall in its...

UK stocks moved higher by midday on Wednesday as investors await the latest update on US monetary policy from the Fed, due later on Wednesday. At 1150, Britain's benchmark FTSE 100 index was up...

Pharmaceutical companies GlaxoSmithKline and Sanofi reached an agreement with the UK government to supply up to 60m doses of a potential Covid-19 vaccine. The vaccine candidate used Sanofi's...

Emma Walmsley, Director, has transferred in 277,623 shares in the company on the 27th July 2020 at a price of 0.000000p. The Director now holds 779,113 shares. Story provided by...

UK stocks traded lower on Monday, with oil companies weighing, as mounting Covid-19 cases stoked fears of a short-lived recovery in the global economy. At 11.35, the benchmark FTSE 100 index was...

UK stocks opened lower on Monday, with oil companies weighing, as mounting Covid-19 cases stoke fears of a short-lived recovery in the global economy. At 0826, the benchmark FTSE 100 index was...

Pharmaceutical giant GlaxoSmithKline invested £104m for a 10% stake in biotech company CureVac, while both companies agreed to develop vaccines and antibodies targeting infectious diseases. The...

UK markets closed sharply higher on Wednesday, bolstered by a firm opening on Wall Street and early promise from a Covid-19 vaccine candidate. Early trading across the pond saw varying gains for...

UK markets continued to climb through late morning on Wednesday, boosted by a firm overnight showing on Wall Street and early promise from a Covid-19 vaccine candidate. Pharmaceutical company...

UK stocks opened higher on Wednesday after a vaccine candidate for Covid-19 showed promising early trail results. At 0829, the benchmark FTSE 100 index was up 55.84 points, or 0.9%, at 6,235.59....

Pharmaceutical company GlaxoSmithKline said an advisory committee of the US Food and Drug Administration had unanimously voted in favor of the use of cancer therapy belantamab mafodotin . The vote...

A late rally for stocks saw the UK's major markets end the trading session higher on Monday despite evidence of economic recovery offset by concerns of a potential resurgence in Covid-19 cases. At...

UK markets made mixed progress through the morning in Monday trade as investors continue to weigh the implications economic recovery against a potential resurgence in Covid-19 cases. At 12.30pm,...

Oddo today reaffirms its neutral investment rating on GlaxoSmithKline PLC (LON:GSK) and raised its price target to 1840p (from 1760p). Story provided by StockMarketWire.com Broker Forecasts data...

The FTSE 100 passed an important psychological hurdle on Monday as it jumped over the 6,000 mark for the first time in almost three weeks amid positive news from a coronavirus vaccine trial. The...

UK stocks made strong gains on Monday as more countries continued to take tentative steps to emerge from coronavirus lockdowns. A surge in oil prices also helped, along with data which showed that...

GlaxoSmithKline said ViiV Healthcare, a joint venture with Pfizer, would end its clinical study of an HIV jab early after achieving its primary goal and showing higher efficacy in preventing the...

UBS today reaffirms its buy investment rating on GlaxoSmithKline PLC (LON:GSK) and raised its price target to 1920p (from 1900p). Story provided by StockMarketWire.com Broker Forecasts data...

GlaxoSmithKline said it expected to receive higher proceeds from the sale of its 5.7% stake Indian public company Hindustan Unilever following an appreciation in the latter's share price. 'When...

JP Morgan Cazenove today reaffirms its neutral investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to 1700p (from 1750p). Story provided by StockMarketWire.com Broker...

Goldman Sachs today reaffirms its buy investment rating on GlaxoSmithKline PLC (LON:GSK) and raised its price target to 2060p (from 1900p). Story provided by StockMarketWire.com Broker Forecasts...

DZ Bank today reaffirms its buy investment rating on GlaxoSmithKline PLC (LON:GSK) and raised its price target to 1950p (from 1900p). Story provided by StockMarketWire.com Broker Forecasts data...

Barclays Capital today reaffirms its underweight investment rating on GlaxoSmithKline PLC (LON:GSK) and raised its price target to 1550p (from 1450p). Story provided by StockMarketWire.com Broker...

Pharma giant GSK said an application for an oral drug to treat women with ovarian cancer had been approved by US health authorities. The US Food and Drug Administration approved the company's new...

Pharmaceutical company GlaxoSmithKline posted a 41% jump in first-quarter earnings after drug sales were boosted by stockpiling amid the Covid-19 pandemic. Operating profit for the three months...

Emma Walmsley, Chief Executive Officer, has re-invested 2,407 shares in the company on the 14th April 2020 at a price of 1567.85p. The Director now holds 755,223 shares. Story provided by...

Emma Walmsley, Chief Executive Officer, has re-invested 2,712 shares in the company on the 14th April 2020 at a price of 1544.20p. The Director now holds 752,816 shares. Story provided by...

Iain Mackay, Executive Director, has re-invested 524 shares in the company on the 14th April 2020 at a price of 1544.20p. The Director now holds 524 shares representing 0.00% of the shares in...

GlaxoSmithKline said it was planning to team up with rival pharmaceutical company Sanofi to develop a vaccine for Covid-19. The two companies had signed a letter of intent to enter into a...

GlaxoSmithKline agreed to buy a stake in Vir Biotechnology for $250m as part of a wider collaboration to development treatments for coronaviruses, including SARS-CoV-2, the virus that causes...

DZ Bank today reaffirms its buy investment rating on GlaxoSmithKline PLC (LON:GSK) and cut its price target to 1900p (from 2000p). Story provided by StockMarketWire.com Broker Forecasts data...